As of 3:59pm ET
| -0.0129 / -3.49%|
The 3 analysts offering 12-month price forecasts for Cytori Therapeutics Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 1.00. The median estimate represents a +1,020.13% increase from the last price of 0.36.
The current consensus among 3 polled investment analysts is to Buy stock in Cytori Therapeutics Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.